Zeon Lifesciences gets patent for ‘synergistic herbal immunomodulatory formulation’ EP News Bureau Jan 17, 2024 The formulation comprises ingredients that are registered with the FSSAI
IndiaRF to acquire API and CRAMS business of Ind-Swift for Rs 1,650 cr EP News Bureau Sep 6, 2023 Ind-Swift reported a consolidated revenue of Rs 1,207 crores and consolidated EBITDA of Rs 256 crores in FY23
Solara Active Pharma and Aurore Life Sciences merge to create pure-play API/CRAMs company EP News Bureau Apr 11, 2021 The Board of Directors of Solara Active Pharma Sciences accepted the recommendations of the Committee of Independent Directors and…